Table 4 Clinical and biological characteristics of K-Ras NSCLC-mutated patients

From: Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

No

Sex

Age (years)

Histological type

Tumour cells count (%)

Stage

Relapse

EFS (months)

Technique using for K-Ras mutation detection

Type of K-Ras mutation

77

M

51

ADC

90

IIB

Yes

2

SQC

G12C

108

F

52

ADC

70

IIIA

Yes

14

SQC

G12C

118

M

68

SCC

60

IB

No

25

SQC

G12D

24

M

58

ADC

60

IB

No

39

SQC

G12C

1109

M

60

ADC-BAC

50

IIB

No

52

SQC

G12A

50

M

54

SCC

50

IA

Yes

20

SQC

G12D

1111

M

66

SCC

50

IA

Yes

8

SQC

G12V

1124

F

44

ADC

50

IIIA

Yes

5

SQC

G12R

1104

M

70

ADC-BAC

40

IIIB

No

44

SQC

G12C

1118

F

53

ADC

40

IV

Yes

1

SQC

G12C

9915

M

60

SCC

40

IIB

Yes

3

SQC

G12V

22013

F

60

SCC

90

IB

No

18

HYB

G12C

52

M

44

ADC

70

IIIA

Yes

22

HYB

G12C

63

F

44

ADC

50

IA

No

49

HYB

G12D

91

M

67

ADC

15

IB

No

18

HYB

G12C

1126

M

74

ADC

1

IA

No

29

HYB

G13C

1116

M

55

ADC

50

IIB

No

26

PNA

G12S

22006

M

56

ADC

50

IIIA

Yes

14

PNA

G12C

1103

M

76

ADC

10

IIIA

Yes

8

PNA

G12D

121

M

45

SCC

1

IB

No

49

PNA

G12C

102

M

56

ADC

1

IIIA

Yes

39

PNA

G12D

  1. ADC=adenocarcinoma; BAC=bronchioloalveolar carcinoma; SCC=squamous cell carcinoma EFS=event-free survival; SQC=results obtained by direct sequencing; HYB=results obtained by hybridisation probe assay; PNA=results obtained by clamped-probe assay.